학술논문
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
Document Type
Article
Author
Fürstenau, Moritz ; Kater, Arnon P; Robrecht, Sandra; von Tresckow, Julia; Zhang, Can; Gregor, Michael; Thornton, Patrick; Staber, Philipp B; Tadmor, Tamar; Lindström, Vesa; Juliusson, Gunnar; Janssens, Ann; Levin, Mark-David; da Cunha-Bang, Caspar; Schneider, Christof; Goldschmidt, Neta; Vandenberghe, Elisabeth; Rossi, Davide; Benz, Rudolf; Nösslinger, Thomas; Heintel, Daniel; Poulsen, Christian B; Christiansen, Ilse; Frederiksen, Henrik; Enggaard, Lisbeth; Posthuma, Eduardus F M; Issa, Djamila E; Visser, Hein P J; Bellido, Mar; Kutsch, Nadine; Dürig, Jan; Stehle, Alexander; Vöhringer, Matthias; Böttcher, Sebastian; Schulte, Clemens; Simon, Florian; Fink, Anna-Maria; Fischer, Kirsten; Holmes, Emily E; Kreuzer, Karl-Anton; Ritgen, Matthias; Brüggemann, Monika; Tausch, Eugen; Stilgenbauer, Stephan; Hallek, Michael; Niemann, Carsten U; Eichhorst, Barbara
Source
In The Lancet Oncology June 2024 25(6):744-759
Subject
Language
ISSN
1470-2045